NCT05903833
Pembrolizumab Combination With Lenvatinib in Pts With Recurrent,Persistent,Metastatic or Locally Advanced Vulvar Cancer Not Amenable to Curative Surgery or Radiotherapy
Phase: Phase 2
Role: Lead Sponsor
Start: Jun 24, 2025
Completion: Oct 30, 2029